Use Of Sphingosine 1 Phosphate Receptor Agonist

Abstract: The present invention relates to use of a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof for the prevention or treatment of atopic dermatitis.

Patent Information

Application #

Filing Date

31 March 2023

Publication Number

47/2023

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

LG CHEM, LTD.

128, Yeoui-daero Yeongdeungpo-gu Seoul 07336

Inventors

1. KIM, Ki Chan

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

2. KIM, Tae Hun

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

Specification

Documents

Application Documents

#	Name	Date
1	202317024561.pdf	2023-03-31
2	202317024561-STATEMENT OF UNDERTAKING (FORM 3) [31-03-2023(online)].pdf	2023-03-31
3	202317024561-REQUEST FOR EXAMINATION (FORM-18) [31-03-2023(online)].pdf	2023-03-31
4	202317024561-FORM 18 [31-03-2023(online)].pdf	2023-03-31
5	202317024561-FORM 1 [31-03-2023(online)].pdf	2023-03-31
6	202317024561-DRAWINGS [31-03-2023(online)].pdf	2023-03-31
7	202317024561-DECLARATION OF INVENTORSHIP (FORM 5) [31-03-2023(online)].pdf	2023-03-31
8	202317024561-COMPLETE SPECIFICATION [31-03-2023(online)].pdf	2023-03-31
9	202317024561-Verified English translation [12-04-2023(online)].pdf	2023-04-12
10	202317024561-Certified Copy of Priority Document [04-05-2023(online)].pdf	2023-05-04
11	202317024561-FORM-26 [30-06-2023(online)].pdf	2023-06-30
12	202317024561-Proof of Right [21-07-2023(online)].pdf	2023-07-21
13	202317024561-FORM 3 [21-07-2023(online)].pdf	2023-07-21
14	202317024561-FER.pdf	2025-02-17
15	202317024561-FORM 3 [11-04-2025(online)].pdf	2025-04-11

Search Strategy

1	202317024561_SearchStrategyNew_E_SearchHistoryE_15-02-2025.pdf